My PCR
Create Account
Logo PCR

18 May 2022

TAVI

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

Sponsored by Abbott

Anchorperson: M. Abdel-Wahab
Moderator: T. Pilgrim
SHOW MORE

Summary

This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.

Learning Objectives

  • To learn how to optimise lifetime management of patients with aortic stenosis
  • To understand how the first bioprosthetic aortic valve may affect long-term outcomes
  • To learn how to refine procedural steps during TAVI
Related Content
How to approach the challenges of large annuli in TAVI Step-by-step TAVI procedure in Europe and India - A review from PCR and India Valves Share your work at PCR-CIT China Chengdu Valves 2025
Recommended for you
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025 PCR Gulf Valves 2025 - Discover the programme New iterations of self expendable valves - LIVE case